Grifols To Boost Its Diagnostics Biz With $1.6 Billion Buy From Novartis
This article was originally published in The Gray Sheet
Executive Summary
The acquisition will expand Grifols’ diagnostic division from its current 4 percent of company sales to more than 20 percent, the Barcelona-based company estimates.